Sangamo Therapeutics (SGMOQ) Change in Receivables (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Change in Receivables of -$152000.0 for Q4 2025, down 200.66% on a QoQ basis from $151000.0 in Q3 2025, and up 98.48% year-over-year from -$76583.8 in Q4 2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Change in Receivables (2010 - 2025) Analysis & Trends
Sangamo Therapeutics has reported Change in Receivables for 16 years, with the latest figure at -$152000.0 in Q4 2025.
- On a quarterly basis, Change in Receivables rose 98.48% year-over-year to -$152000.0 in Q4 2025; TTM through Dec 2025 was -$155000.0, a 60.96% increase from a year earlier, with the FY2025 full-year figure at -$155000.0, up 60.96% from the prior year.
- Change in Receivables was -$152000.0 for Q4 2025 at Sangamo Therapeutics, down from $151000.0 in the prior quarter.
- The five-year high for Change in Receivables was $9.9 million in Q3 2024, with the low at -$10.0 million in Q4 2024.
- Average Change in Receivables over 5 years is -$242650.0, with a median of -$156000.0 recorded in 2025.
- The largest YoY upside for Change in Receivables was 732.33% in 2024 against a maximum downside of 4331.11% in 2024.
- Over 5 years, Change in Receivables stood at -$2.0 million in 2021, then surged by 56.81% to -$844000.0 in 2022, then soared by 73.34% to -$225000.0 in 2023, then tumbled by 4331.11% to -$10.0 million in 2024, then jumped by 98.48% to -$152000.0 in 2025.
- The last three Change in Receivables figures came in at -$152000.0 (Q4 2025), $151000.0 (Q3 2025), and $6000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 11.97 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 20.36 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.60 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 45.46 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -17.99 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 3.33 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -152,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -160,000.00 |
| Dec 31, 2024 | -9.97 Mn |
| Sep 30, 2024 | 9.92 Mn |
| Jun 30, 2024 | -110,000.00 |
| Mar 31, 2024 | -232,000.00 |
| Dec 31, 2023 | -225,000.00 |
| Sep 30, 2023 | -1.57 Mn |
| Jun 30, 2023 | -4.31 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | -844,000.00 |
| Sep 30, 2022 | -1.48 Mn |
| Jun 30, 2022 | -936,000.00 |
| Mar 31, 2022 | 925,000.00 |
| Dec 31, 2021 | -1.95 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 136,000.00 |
| Mar 31, 2021 | 1.52 Mn |